Recruiting
Phase 2

A Study of RSLV-132 in Females with Primary Sjögren's Syndrome

Sponsor:

Resolve Therapeutics

Code:

NCT06440525

Conditions

Primary Sjögren Syndrome

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

RSLV-132

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information